Please login to the form below
8
Revenue 2017AbbVie
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AbbVie's 2013 sales performance.
AbbVie shares positive results from head-to-head study of Skyrizi in Crohn's disease
AbbVie has shared positive top-line results from a head-to-head study of its interleukin-23 inhibitor Skyrizi (risankizumab) in Crohn's disease. ... All secondary endpoints achieved statistical significance for superiority versus Stelara, AbbVie said,
Novartis sues US government over Medicare drug price negotiation programme
Johnson &Johnson's Stelara (ustekinumab) and Xarelto (rivaroxaban) were also listed, as well as its AbbVie-partnered Imbruvica (ibrutinib).
US government announces first ten drugs subject to Medicare pricing negotiations
Johnson &Johnson's Stelara (ustekinumab) and Xarelto (rivaroxaban) are also listed, as well as its AbbVie-partnered Imbruvica (ibrutinib).
AstraZeneca’s rare disease unit to acquire Pfizer’s early-stage gene therapies for $1bn
The company, along with AbbVie, Amgen, Bayer and Merck, will now co-fund the whole-genome sequencing of 250, 000 samples and have access to the resulting data for use in
AbbVie doses first patient in phase 3 study of Rinvoq in hidradenitis suppurativa
AbbVie has announced that the first patient has been dosed in a late-stage study of its selective JAK inhibitor, Rinvoq (upadacitinib), in adults and adolescents with moderate-to-severe hidradenitis ... There is no cure for HS, and there are limited
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Medscape Education Global
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
